It is suggested that the decrease in 25(OH)D levels in MetS is due to 25(OH)D binding in body fat [117], and PTH elevation is considered to be a compensatory mechanism for low 25(OH)D levels. The gene discussed is PTH; the disease is metabolic syndrome.